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Abstract: This paper presents an analysis of healthy immune system dynamics from the
perspective of finite time stability. Finite time stability and stabilisation have been well-studied
in various engineering applications. The principal paradigm uses non-Lipschitz functions of the
states. Recent studies on robustness of closed-loop non-Lipschitz dynamical systems are based
on Lyapunov functions and show that finite time stability is both a special case of and superior
to the asymptotic stability of the system. Such a finite time convergence property has not been
studied extensively in the area of biological systems where it is evident that the dynamics are
finite time convergent to certain equilibrium points rather than asymptotically or exponentially
convergent. Furthermore, there are examples such as a healthy immune system response where
robustness is found to the state of auto-immune disease. These inherent features of robustness
and finite time convergence motivate the development of a modified version of the Michaelis-
Menten function, which is frequently used in biology, based on the finite time stability paradigm.
The paper hypothesizes a potential connection between finite time stability and the dynamics
of a healthy immune system.
1. INTRODUCTION
Finite time stability has been studied rigorously and is
an efficient robust control paradigm. It is a special case
of asymptotic stability with the principal feature being
that the states of the dynamical system reach the origin
in finite time as opposed to infinite time. Several results
exist in the area. The foundations can be traced back to
results in the area of optimal control (see Fuller (1960))
where finite time convergence was shown to occur when a
discontinuous controller was used.
Amongst the theoretical control studies, the convergence
of the states to the origin can be achieved either via con-
tinuous or discontinuous control. Amongst the continuous
control algorithms, early work by Haimo (1986) showed
that the non-Lipschitz continuous controllers can produce
a closed-loop system with states converging to the origin in
finite time. Work by Bhat and Bernstein (2000) formalised
Lyapunov theorems for continuous finite time stability.
This area has developed from these early results and a
brief literature review can be found in Bernuau et al.
(2012). Amongst the discontinuous control paradigms, the
area of first and second order sliding mode control belong
to the class of robust control techniques where the states
either reach a manifold or the origin in finite time. Since
the first results of Utkin (1977), sliding mode control has
been recognised as a popular robust control technique. The
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theory of second order sliding mode control developed in
Levant (1993) is a robust control result that ensures finite
time convergence of the states of a second order system to
the origin in the presence of bounded perturbations. A gen-
eral result concerning finite time stability of discontinuous
systems can be found in Orlov (2005). The latest advances
in this area focus on studying explicit Lyapunov functions
as can be seen by the recent literature of Polyakov and
Poznyak (2009); Orlov et al. (2010) and Moreno (2012).
The main focus of this paper is in studying finite time
stability properties of the dynamics of a healthy immune
system. A new modelling environment for the immune
system is thus hypothesized. Study of the immune system
from a systems biology perspective continues to attract
the interest of researchers. Immune system dynamics is a
fundamental example of a biological system with bistable
behaviour. Pathologies related to the immune system
lead to a number of human diseases including psoriasis,
arthritis, cancer, atherosclerosis, diabetes, inflammatory
bowel disease and asthma. This paper studies the healthy
equilibrium of the immune system dynamics.
Immune system dynamics, as with any other biological
system, evolve over a finite time interval as opposed to
infinite time. For example, individual clonal immune cell
populations are required to expand and become activated
for a limited time. The existing literature has rigorously
provided systems theoretic results for studying asymptotic
convergence of the states to certain equilibria (see for ex-
ample Perelson (2002) and Rapin et al. (2011)). However,
rigorous study from a systems biology viewpoint has not
been carried out to explore finite time stability. Given
a rich mathematical background and the availability of
sound results in the theory of continuous and discontinu-
ous finite time stabilisation, there exists an opportunity to
study the immune system dynamics from this control the-
oretic perspective. The principal motivation of the paper is
to explore if there exists a connection between the mathe-
matically known consequence of finite time stability when
using non-Lipschitz functions and the natural observation
of finite time convergence in biological system dynamics
such as that of a healthy immune system.
The proposed study of finite time stability is carried out
as follows. The paper considers two existing models of the
immune system dynamics and proposes modifications to
generate finite time stability of the healthy equilibrium.
The first model is the cell-level dynamics given by Rapin
et al. (2011) and the second model is that given by Valeyev
et al. (2010) for the cytokine level dynamics. As discussed
in the reported literature, finite time stability cannot be
modelled in the absence of non-Lipschitz functions on the
right hand side of differential equations. This becomes
the main basis for proposing a non-Lipschitz version of
the well-known Michaelis-Menten function (see references
Lebl (2013); Porter and Miller (2012) for a survey and
references Valeyev et al. (2008a,b) for recent applications).
The paper considers if the existing qualitative features of a
healthy immune system remain while giving mathematical
evidence of finite time convergence thereby narrowing the
gap between the natural biological occurrence of finite time
stability and the underlying models that should capture
such observed behaviour.
The paper is structured as follows. Section 2 begins the
discussion with a modified version of the Michaelis-Menten
function. Section 3 then explores connections with finite
time stability for two system models of the immune system
dynamics. Section 4 presents the conclusions.
2. A MODIFIED VERSION OF THE
MICHAELIS-MENTEN FUNCTION
A modified version of the Michaelis-Menten function is
discussed in this section. The motivation to introduce
a new version lies in the possibility of modelling the
naturally occuring finite-time behaviour of the healthy
immune system. This is discussed in more detail in the
next section. The Michaelis-Menten function involving the





where kmax is the maximum or the saturation value
attainable in the range of the function f(x) and kmaxkm
defines the slope of the graph of f(x) at x = 0. A
normalized version of (1) as utilised in Valeyev et al. (2010)





A non-Lipschitz modification of the above function is





Fig. 1. Modified Michaelis-Menten function
where α ∈ (0, 1). The non-Lipschitz function f¯(x) of (3)
equals f(x) of (2) for α = 1. The limiting values of
f¯(x) as x tends to zero and infinity remain the same
as those of f(x). The main difference between these two
functions is that f¯(x) approaches zero with an infinite
slope as it is non-Lipschitz in x whereas f(x) has a
slope (1 + x)−2 everywhere. The graphs of f(x) and f¯(x)
against x are shown in Fig. 1 with α = 0.5. It is noted
that f(x) takes the value 12 at x = 1 whereas f¯(x) =
( 12 )
α at x = 1. Small values of the constant km in (1)
correspond to a higher slope closer to the origin and to
stronger attraction of the trajectories towards the resulting
equilibrium. The modified Michaelis-Menten function (3)
mimics this characteristic for those values of α smaller
than unity.
3. MODELS PRESCRIBING FINITE TIME
STABILITY
Such a modification as proposed above comes from the
viewpoint of modelling a personalised immune response
that is healthy with a stronger attraction towards a
healthy equilibrium. Modelling analysis in the existing
literature focusses on asymptotic stability of healthy or
unhealthy equilibria of the immune system (see Rapin
et al. (2011)). Typically, the vector field is linearised about
the equilibrium and the eigenvalues of the resulting system
matrix are analysed. Such an analysis gives good insight
into the qualitative asymptotic behaviour of the system
close to the equilibrium.
However, it is evident from the observation of biological
systems that the dynamics are finite time convergent to
the given equilibrium point rather than asymptotically
or exponentially convergent. To the authors’ knowledge,
there is no existing work which can rigorously model the
finite time behaviour which is a key characteristic of the
underpinning biology. This section is motivated by the
need to analyse the decay in the concentration or cell
populations to the equilibrium in a finite time as this
may be a more realistic way of modeling compared to that
on an infinite time scale. The tools for stability analysis
from linear system theory can no longer be applied to
the resulting non-Lipschitz dynamical system. However,
there are well defined mathematical tools available in
the literature as defined in Bhat and Bernstein (2000).
Furthermore, the motivation to study a new modelling
framework also lies in the possibility of proposing new
treatment regimes which, like the existing ones, inherently
need to be defined on a finite time scale as do cell deaths.
With the above viewpoint, the modified Michaelis-Menten
functions as defined in (3) can be used to model a person-
alised immune response function. Two different models are
considered relating to the immune system in the following
sub-sections. The first model builds on the linearised im-
mune system model given by Rapin et al. (2011) which
captures cell level dynamics and the second model builds
on the cytokine dynamics presented in Valeyev et al.
(2010).
3.1 Cell population dynamics
The first model considered is the immune systems model
given in Rapin et al. (2011) as follows:




− f x3 (4)
where, x1 represents the tissue cells, x2 represents the
damaged cells and x3 represents the immune cells. The
positive scalars l, d, k, e,m, h, f are defined in Rapin et al.
(2011). Consider the following linear model derived by
linearising the non-linear dynamics around the equilibrium
point (x1, x2, x3) = (
l
d , 0, 0) as derived in Rapin et al.
(2011):
x˙1 = −dx1 − k l
d
x3, x˙2 = −ex2 + k l
d
x3, x˙2 = −fx3
(5)
The model parameters d, e, f represent respectively the
death rate constants of the three states 1 . The proposed
modification of the model using the non-Lipschitz function





























where α = 0.98 is used. Model (6) possesses a different set
of equilibria when compared to (5). The equilibria depend
on α. The justification for introducing such variability
lies in the fact that it is unlikely that every immune
system possesses a distinctly defined equilibrium and the
same model parameters. Thus, the parameter α represents
various responses for a class of immune system dynamics.
There are a number of properties of this model that can
be observed.
For non-negative initial conditions, the quantity xi1+xi , i =
1, 2, 3 always remains positive. Furthermore, the time
varying scalar k¯(x3) =
1
(1+x3)α
remains positive. The third
equation in (6) can be re-written as
x˙3 = −fk¯(x3)xα3 , (7)
which is a finite time stable equation as per Bhat and
Bernstein (2000, Th. 4.2). This can be formally verified





1 Refer to Rapin et al. (2011) for values of the model constants
Fig. 2. Comparison of evolution of state x1 of the dynamics
(6)
temporal derivative along the scalar system equation (7)
V˙ = −fk¯(x3)xα+13 . Since xα+13 = (2V )
α+1
2 , the equality
V˙ ≤ −2α+12 fκV α+12 (8)
holds true for some scalar 1 ≥ k¯(x3) ≥ 12 > κ > 0. Such
a scalar κ ∈ (0, 12 ) can always be found globally for all x3.
This is because (8) shows global asymptotic stability and
there exists a finite time t = t1 after which the expressions
supx3≥0 k¯(x3) = 1, x3 < 1, (1 + x3)







= − ¯κ(x3) ≤ −1
2
≤ −κ
hold true for all α ∈ (0, 1). Hence, the well-known result
of finite time stability using Lyapunov analysis (Theorem
4.2 of Bhat and Bernstein (2000)) applies since α+12 ∈
(0, 1) ∀α ∈ (0, 1). This leads to the equality x3 = 0 in
finite time instead of asymptotically.
After a finite time instant t = T < ∞ for which the
identity x3 = 0 holds true for all t ≥ T , the remaining












These, in turn, are finite time convergent to the origin
x1 = 0, x2 = 0 following a similar analysis as carried
out for the state x3. This analysis shows that the model
(6) imitates the linear model (5) in that the stability of
the healthy equilibrium point is maintained. However, the
stability of the states is a finite time behaviour, which
is a special case of asymptotic stability (see Bhat and
Bernstein (2000)). Hence, the proposed model (6) captures
a class of finite time healthy immune system responses that
have the same qualitative stability properties as the linear
model for the healthy equilibrium.
Due to the finite time convergence properties shown, the
proposed model can be seen to capture a more robust
immune system. Consider the initial condition response
for models (5) and (6). The evolution of each of the states





(1, 0, 0.05). The immune cells x3 and the damaged cells x2
go to zero slightly quicker for the non-linear model. Here,
α is seen as a modelling parameter dictating the finite time
behaviour.
3.2 A Cytokine dynamics of an immune system
This section proposes the study of finite time stability
with respect to a model proposed in Valeyev et al. (2010).
Valeyev et al. (2010) proposed a systems model for immune
cell interactions to study the mechanism of inflammatory
disease in human skin. The authors highlighted the need
for development of a model that gives more insight into
how various cytokine production scenarios can comple-
ment the genome-wide association studies and expression
level comparison studies for studying how the immune
system operates. The normalised model given in the Sec-
tion “Materials and Methods” of the article Valeyev et al.
(2010) for capturing the interdependence of cytokines x1

































The variables x1(t) and x2(t) represent the concentrations
of cytokine A and B respectively. The corresponding non-
normalised equations and the definitions of the units of the
associated model entities can be found in Valeyev et al.
(2010). The model parameters can be found in Table 1
of the reference of Valeyev et al. (2010). In the following
analysis, it is assumed that i1(t) = i2(t) = 0. The system
model (10) is a highly non-linear model and unlike the
linear dynamics, the stability points are generally difficult
to find. The approach in Valeyev et al. (2010) is to find the
equilibrium points numerically by setting the right hand
sides of each of the equations in (10) to zero and locating
the intersection. Fig. 3 shows typical null clines, or lines of
Fig. 3. Lines of equilibrium of the dynamics (10) with
bistable behaviour
Fig. 4. Lines of equilibrium of the dynamics (11) for the
stable homeostasis
equilibrium for the dynamics of (10) for the case when the
model parameters induce a bistable behaviour. The legend
entry F1 = 0 represents that set of points in the (x1, x2)
state-plane where the expression x˙1 = 0 holds. Similarly,
the legend entry F2 = 0 represents that set of points in
the (x1, x2) state-plane where the expression x˙2 = 0 holds.
Refer to Valeyev et al. (2010) for a detailed analysis of the
resulting dynamics of the immune system.
It can be seen that model (10) makes use of the Michaelis-
Menten function in its original normalised form (2). Simi-
lar to Section 3.1, the intention is to explore the behaviour
of the model by substituting the non-Lipschitz growth









































1 + x21+x2 +
d
1+x2
) −D(x2 − ck)
(11)
where the scalar α > 0 becomes a model constant that
parameterises the immune system response. It should be
noted that when going from (10) to (11), the non-Lipschitz
growth function is performed only for the terms of the form
xi/(k + xi) for some k = 1 or k = kMP and i = 1, 2 with
the exception of the term
− 1




where i = 1, 2 since this term is not non-Lipschitz and
does not affect the overall dynamics in the way that the
other non-Lipschitz terms do. In other words the term
(12) can be shown to be bounded from above by the term
−1/(2+d) and does not contribute towards any finite time
convergence characteristics. It is interesting to study if
the original qualitative behaviour remains for the healthy
equilibrium despite the above changes. Fig. 4 shows the
behaviour of the vector field (11) for the stable homeostasis
in terms of the equilibrium lines F1 = 0, F2 = 0 for three
cases. The black lines represent the original case, i.e. α = 1,
Fig. 5. Lines of equilibrium for dynamics (11) for the
oscillatory homeostasis
Fig. 6. State response for the dynamics (11) for the stable
homeostasis
the red lines represent the case when α = 0.95 and the
green lines represent the case when α = 0.85 is used. A
similar qualitative behaviour is shown for the oscillatory
homeostasis in Fig. 5. The equilibrium manifolds F1 =
0, F2 = 0 vary with the variation in α. However, the
qualitative behaviour of the systems model remains the
same, representing a stable healthy equilibrium mode (see
Fig. 4) and an unstable oscillatory mode (see Fig. 5) for
auto-immune disease for the presented range of α since the
location of the equilibrium points of interest do not change
drastically. Fig. 6 shows the time response of the cytokine
concentrations x1, x2 for the stable homeostasis of Fig. 4.
Parameterisations of Model constants based on finite time
stability analysis
Finite time stability of dynamical systems has been stud-
ied extensively. There are two generic problems that are of
relevance to the study carried out in this section. Amongst
discontinuous systems, results on second and higher order
sliding mode systems pertaining to finite time stabilisation
solve the first problem via Lyapunov analysis, namely,
proving that the system states converge to the desired ones
in finite time (see references Orlov (2005); Moreno (2012);
Orlov et al. (2010)). The results that make use of non-
Lipschitz continuous controllers for second order systems
can be found in Bhat and Bernstein (1998); Hong et al.
(2001). The converse problem then becomes one of finding
the gains of the controller given the desired convergence
time of the closed-loop system. Results in this area of study
can be found in Oza et al. (2012).
The preceding sections studied the first problem for the
healthy immune system dynamics, namely, if the system
settles at the equilibrium given the structure of the model
and fixed values of model constants. This section attempts
to study the converse problem for the proposed modi-
fications of the model. More precisely, the intention is
to find parameterisations or sets of values for the model
constants for which finite time convergence of the states
is guaranteed. Motivation for such an analysis lies in the
ultimate goal of gaining more insight into stable behaviour
of the auto-immune dynamics and exploring opportunities
for building a desired model for therapeutic purposes as
the model constants can be influenced by drug regimes.
To this effect, consider the stable homeostasis of the
dynamics (11). The approach used in the following is that
of analysing bounding solutions (or the majorant curves
as utilised in Levant (1993)) to find the conditions for
finite time convergence while treating the model constants
as controller gain-like terms. It is reasonable to assume
|x1| < 1 close to the stable origin as can be seen from Fig 4.
It is also true that the expression supx2≥0 1/(1 + x2) = 1
always holds true. Furthermore, the expression−1/(kMP+
x1)










≤ 2 + d
⇒ −1






always holds true for all 1 > x1 ≥ 0. Combining these
simplifications, the first equation in (11) can be re-written
as follows for kMP = 0.6:







−D(x1 − ck) (14)
In the vicinity of the origin where 1 > |x1| > ck = 0.25,
the finite time convergence of the state x1 to the set
{(x1, x2) : max{|x1|, |x2|} ≤ ck} is always guaranteed for
the finite time stable equation (14). This can be formally
proved by employing a Lyapuov analysis as presented in
Section 3.1 provided the following condition holds true:
a1 − a2
2 + d
−MP < 0 (15)
It can be seen that the set {(x1, x2) : max{|x1|, |x2|} ≤ ck}
contains the stable equilibrium which is the intersection of
the two equilibrium lines for all the cases in Fig. 4. A
similar analysis can be performed for the second equation
in the vicinity of the stable equilibrium where x1 < 1 so
that x1/(1 + x1) ≤ 1 holds true. The resulting majorant
solution for the second equation can be obtained as follows:









The condition for finite time convergence of the state x2 to
the set {(x1, x2) : max{|x1|, |x2|} ≤ ck} is thus obtained:
a3 − a4
2 + d
−MP < 0 (17)
Fig. 7. State response for the dynamics (11) for the a priori
guaranteed stable homeostasis
Equations (15) and (17) prescribe conditions on the model
parameters in a similar way to the controller tuning anal-
ysis presented in Oza et al. (2012) for a general perturbed
double integrator system. Hence, the above analysis builds
an analogue to the existing control theoretical results for
the reported immune system dynamics while extending the
modelling framework to encompass a more general immune
system response. The equilibrium lines for the system with
an priori guarantee of finite time stability are shown in
Fig. 7 where the parameters a1 = 0.16, a2 = 0.34, a3 =
a4 = 0.03,MP = 0.024, ck = 0.25, kMP = 0.6, d = 0.5
are used such that conditions (15) and (17) are satisfied.
It can be seen from Fig. 7 that such an immune system
does not exhibit any unstable modes and hence finite time
convergence to the set containing the resulting healthy
equilibrium is the only possible outcome.
4. CONCLUSION
A non-Lipschitz growth function has been proposed in this
paper. Motivated by the observation of naturally occurring
finite time convergence in biological systems and by the
recent advances in robust control systems, a new modelling
framework for immune system dynamics was proposed and
analysed. The problem of parameterising the constants of
the proposed model was undertaken based on both the
intuitively known fact of biological finite time stability
of naturally occurring dynamics and the corresponding
mathematical analysis. Extending this approach to higher
dimensional models can be identified as a future objective.
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